Edwards Lifesciences (EW) Financial Analysis & Valuation | Quarter Chart

Edwards Lifesciences (EW)

EW
Price: $91.18
Fair Value: 🔒
🔒score
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of hea... more
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, an... more
Description Shares
Market Cap$52.50BExchangeNYSE
SectorHealthcareIndustryMedical - Devices
CountryUSCEOBernard J. Zovighian
IPO Date2000-03-27CAGR0.08%
Employees15,800Websitewww.edwards.com
Div. Yield—Payout Ratio—
Buy Back Yield0.73%Total Yield0.73%
EW chart loading...
Fundamentals Technicals
Enterprise Value$47.75BP/E Ratio33.77
Forward P/E27.08PEG Ratio6.01
P/S Ratio8.85P/B Ratio5.43
P/CF Ratio41.32P/FCF Ratio51.21
EPS$2.7EPS Growth 1Y-73.14%
EPS Growth 3Y-21.99%EPS Growth 5Y39.26%
Revenue Growth 1Y13.81%Gross Margin0.78%
Operating Margin0.28%Profit Margin0.17%
ROE0.11%ROA0.08%
ROCE0.15%Current Ratio4.42
Quick Ratio3.63Cash Ratio1.74
Debt/Equity0.07Interest Coverage—
Altman Z Score12.99Piotroski Score6

View Edwards Lifesciences financial charts →